In vivo small animal imaging: Current status and future prospects

George C. Kagadis, George Loudos, Konstantinos Katsanos, Steve G. Langer, George C. Nikiforidis

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

The use of small animal models in basic and preclinical sciences constitutes an integral part of testing new pharmaceutical agents prior to commercial translation to clinical practice. Whole-body small animal imaging is a particularly elegant and cost-effective experimental platform for the timely validation and commercialization of novel agents from the bench to the bedside. Biomedical imaging is now listed along with genomics, proteomics, and metabolomics as an integral part of biological and medical sciences. Miniaturized versions of clinical diagnostic modalities, including but not limited to microcomputed tomography, micromagnetic resonance tomography, microsingle-photon-emission tomography, micropositron-emission tomography, optical imaging, digital angiography, and ultrasound, have all greatly improved our investigative abilities to longitudinally study various experimental models of human disease in mice and rodents. After an exhaustive literature search, the authors present a concise and critical review of in vivo small animal imaging, focusing on currently available modalities as well as emerging imaging technologies on one side and molecularly targeted contrast agents on the other. Aforementioned scientific topics are analyzed in the context of cancer angiogenesis and innovative antiangiogenic strategies under-the-way to the clinic. Proposed hybrid approaches for diagnosis and targeted site-specific therapy are highlighted to offer an intriguing glimpse of the future.

Original languageEnglish (US)
Pages (from-to)6421-6442
Number of pages22
JournalMedical Physics
Volume37
Issue number12
DOIs
StatePublished - Dec 2010

Fingerprint

Tomography
X-Ray Microtomography
Metabolomics
Biological Science Disciplines
Optical Imaging
Genomics
Photons
Proteomics
Contrast Media
Rodentia
Angiography
Theoretical Models
Animal Models
Technology
Costs and Cost Analysis
Pharmaceutical Preparations
Neoplasms
Therapeutics

Keywords

  • digital angiography
  • hybrid imaging
  • micro-CT
  • micro-MRI
  • micro-PET
  • micro-SPECT
  • molecular imaging
  • optical imaging
  • small animal imaging
  • ultrasound

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

Kagadis, G. C., Loudos, G., Katsanos, K., Langer, S. G., & Nikiforidis, G. C. (2010). In vivo small animal imaging: Current status and future prospects. Medical Physics, 37(12), 6421-6442. https://doi.org/10.1118/1.3515456

In vivo small animal imaging : Current status and future prospects. / Kagadis, George C.; Loudos, George; Katsanos, Konstantinos; Langer, Steve G.; Nikiforidis, George C.

In: Medical Physics, Vol. 37, No. 12, 12.2010, p. 6421-6442.

Research output: Contribution to journalArticle

Kagadis, GC, Loudos, G, Katsanos, K, Langer, SG & Nikiforidis, GC 2010, 'In vivo small animal imaging: Current status and future prospects', Medical Physics, vol. 37, no. 12, pp. 6421-6442. https://doi.org/10.1118/1.3515456
Kagadis GC, Loudos G, Katsanos K, Langer SG, Nikiforidis GC. In vivo small animal imaging: Current status and future prospects. Medical Physics. 2010 Dec;37(12):6421-6442. https://doi.org/10.1118/1.3515456
Kagadis, George C. ; Loudos, George ; Katsanos, Konstantinos ; Langer, Steve G. ; Nikiforidis, George C. / In vivo small animal imaging : Current status and future prospects. In: Medical Physics. 2010 ; Vol. 37, No. 12. pp. 6421-6442.
@article{026b28d9413944c5b5c9ad70d2b2a998,
title = "In vivo small animal imaging: Current status and future prospects",
abstract = "The use of small animal models in basic and preclinical sciences constitutes an integral part of testing new pharmaceutical agents prior to commercial translation to clinical practice. Whole-body small animal imaging is a particularly elegant and cost-effective experimental platform for the timely validation and commercialization of novel agents from the bench to the bedside. Biomedical imaging is now listed along with genomics, proteomics, and metabolomics as an integral part of biological and medical sciences. Miniaturized versions of clinical diagnostic modalities, including but not limited to microcomputed tomography, micromagnetic resonance tomography, microsingle-photon-emission tomography, micropositron-emission tomography, optical imaging, digital angiography, and ultrasound, have all greatly improved our investigative abilities to longitudinally study various experimental models of human disease in mice and rodents. After an exhaustive literature search, the authors present a concise and critical review of in vivo small animal imaging, focusing on currently available modalities as well as emerging imaging technologies on one side and molecularly targeted contrast agents on the other. Aforementioned scientific topics are analyzed in the context of cancer angiogenesis and innovative antiangiogenic strategies under-the-way to the clinic. Proposed hybrid approaches for diagnosis and targeted site-specific therapy are highlighted to offer an intriguing glimpse of the future.",
keywords = "digital angiography, hybrid imaging, micro-CT, micro-MRI, micro-PET, micro-SPECT, molecular imaging, optical imaging, small animal imaging, ultrasound",
author = "Kagadis, {George C.} and George Loudos and Konstantinos Katsanos and Langer, {Steve G.} and Nikiforidis, {George C.}",
year = "2010",
month = "12",
doi = "10.1118/1.3515456",
language = "English (US)",
volume = "37",
pages = "6421--6442",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "12",

}

TY - JOUR

T1 - In vivo small animal imaging

T2 - Current status and future prospects

AU - Kagadis, George C.

AU - Loudos, George

AU - Katsanos, Konstantinos

AU - Langer, Steve G.

AU - Nikiforidis, George C.

PY - 2010/12

Y1 - 2010/12

N2 - The use of small animal models in basic and preclinical sciences constitutes an integral part of testing new pharmaceutical agents prior to commercial translation to clinical practice. Whole-body small animal imaging is a particularly elegant and cost-effective experimental platform for the timely validation and commercialization of novel agents from the bench to the bedside. Biomedical imaging is now listed along with genomics, proteomics, and metabolomics as an integral part of biological and medical sciences. Miniaturized versions of clinical diagnostic modalities, including but not limited to microcomputed tomography, micromagnetic resonance tomography, microsingle-photon-emission tomography, micropositron-emission tomography, optical imaging, digital angiography, and ultrasound, have all greatly improved our investigative abilities to longitudinally study various experimental models of human disease in mice and rodents. After an exhaustive literature search, the authors present a concise and critical review of in vivo small animal imaging, focusing on currently available modalities as well as emerging imaging technologies on one side and molecularly targeted contrast agents on the other. Aforementioned scientific topics are analyzed in the context of cancer angiogenesis and innovative antiangiogenic strategies under-the-way to the clinic. Proposed hybrid approaches for diagnosis and targeted site-specific therapy are highlighted to offer an intriguing glimpse of the future.

AB - The use of small animal models in basic and preclinical sciences constitutes an integral part of testing new pharmaceutical agents prior to commercial translation to clinical practice. Whole-body small animal imaging is a particularly elegant and cost-effective experimental platform for the timely validation and commercialization of novel agents from the bench to the bedside. Biomedical imaging is now listed along with genomics, proteomics, and metabolomics as an integral part of biological and medical sciences. Miniaturized versions of clinical diagnostic modalities, including but not limited to microcomputed tomography, micromagnetic resonance tomography, microsingle-photon-emission tomography, micropositron-emission tomography, optical imaging, digital angiography, and ultrasound, have all greatly improved our investigative abilities to longitudinally study various experimental models of human disease in mice and rodents. After an exhaustive literature search, the authors present a concise and critical review of in vivo small animal imaging, focusing on currently available modalities as well as emerging imaging technologies on one side and molecularly targeted contrast agents on the other. Aforementioned scientific topics are analyzed in the context of cancer angiogenesis and innovative antiangiogenic strategies under-the-way to the clinic. Proposed hybrid approaches for diagnosis and targeted site-specific therapy are highlighted to offer an intriguing glimpse of the future.

KW - digital angiography

KW - hybrid imaging

KW - micro-CT

KW - micro-MRI

KW - micro-PET

KW - micro-SPECT

KW - molecular imaging

KW - optical imaging

KW - small animal imaging

KW - ultrasound

UR - http://www.scopus.com/inward/record.url?scp=78650150918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650150918&partnerID=8YFLogxK

U2 - 10.1118/1.3515456

DO - 10.1118/1.3515456

M3 - Article

C2 - 21302799

AN - SCOPUS:78650150918

VL - 37

SP - 6421

EP - 6442

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 12

ER -